FOXO4-DRI
D-retro-inverso FOXO4 peptide that disrupts the FOXO4-p53 interaction in senescent cells. Studied as a targeted senolytic for clearing p21-positive cells to reduce senescence burden.
0 anonymous reports
Also known as:
foxo4 peptidesenolytic peptidefoxo4-p53 inhibitor
browse topics:
community guides:
No reports found.
Community Q&A
- What does FOXO4-DRI do?
- Community accounts describe FOXO4-DRI as one of the most conceptually exciting senolytic peptides — targeting the mechanism by which senescent cells resist apoptosis. By disrupting the FOXO4-p53 binding that protects senescent cells from dying, FOXO4-DRI is described in accounts as triggering selective clearance of these cells. Confessions from users frame it as a longevity intervention targeting the root cause of cellular aging rather than downstream effects.
- What have community members reported from FOXO4-DRI?
- Community accounts on FOXO4-DRI are sparser and more cautious than most peptide categories — reflecting its experimental status. The most commonly described subjective effects: improved energy, reduced joint discomfort, and a general sense of physiological improvement over 4–8 week protocols. Accounts acknowledge difficulty attributing effects to FOXO4-DRI specifically, as most users run it alongside other longevity compounds. No consensus on optimal dosing exists in community reports.